Aridis Pharmaceuticals, Inc.

OTCPK:ARDS Stock Report

Market Cap: US$53.0

Aridis Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:ARDS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 Jun 24BuyUS$50,000Vu TruongIndividual714,286US$0.07
24 Jun 24BuyUS$50,000Eric PatzerIndividual714,286US$0.07

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ARDS?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,763,4123.31%
Individual Insiders2,324,0904.36%
Hedge Funds4,626,1908.68%
Institutions5,168,7329.69%
General Public39,438,46874%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.6%.


Top Shareholders

Top 9 shareholders own 26.04% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.69%
Cystic Fibrosis Foundation, Endowment Arm
5,168,732US$5.10%no data
8.68%
Armistice Capital LLC
4,626,190US$4.60%no data
2.59%
Vu Truong
1,378,639US$1.40%no data
1.66%
AstraZeneca PLC
884,956US$0.90%no data
1.66%
Eric Patzer
884,600US$0.90%no data
1.65%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
878,456US$0.90%no data
0.1%
Fred Kurland
53,751US$0.050%no data
0.0096%
Hasan Jafri
5,100US$0.0050%no data
0.0037%
John Hamilton
2,000US$0.0020%no data